04/16/2025
6:02 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/01/2025
6:02 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2025
6:50 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
10:50 AM | Purple Biotech (Filer)
| Form 6-K/A | |
03/10/2025
8:01 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2025
6:02 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025
6:01 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025
6:04 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025
4:26 PM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2024
6:30 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
6:21 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for PPBT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. |
12/04/2024
10:40 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024
8:50 AM | Purple Biotech (Filer)
| Form 424B5 | |
12/02/2024
6:03 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024
6:02 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
4:21 PM | ARMISTICE CAPITAL, LLC (Filed by)
Purple Biotech (Subject)
| Form SC 13G/A | |
11/04/2024
6:51 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
6:20 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/10/2024
6:40 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024
6:41 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
5:32 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:15 PM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024
7:14 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024
11:15 PM | Purple Biotech (Filer)
| Form EFFECT | |
07/25/2024
6:36 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/22/2024
4:00 PM | Purple Biotech (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
07/19/2024
7:53 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024
3:15 PM | Purple Biotech (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/01/2024
8:05 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024
6:47 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
8:16 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024
5:21 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
6:40 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024
6:10 AM | Purple Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy PPBT Stock Free PPBT Stock Alerts